ALLODX
Product Updates
AlloDx launches CompliTCC™ sC5b-9 test
AlloDx launches CompliTCC™ sC5b-9 test
Read more ↗
AlloDx CompliNeF™ Assay: Reading C3NeF Function Through Bb Retention
2026-09-23 A reliable C3NeF assay should not only reflect the functional changes of C3 convertase, but also minimize the interference of anti-IgG signals. If C3NeF is regarded as an ordinary natural
Read more ↗
Genetic testing should not stop at finding mutations
Core point of view: Detecting variants is only the starting point; only by putting the variants back into the context of kidney disease and kidney transplantation can we form more clinically valuable…
Read more ↗
AlloDx SuperNAT: Advancing Nephrin Antibody Testing in Podocyte Disease
In recent years, Nephrin antibodies have attracted increasing attention from the nephrology community as potential biomarkers for podocyte-related diseases such as minimal change disease (MCD) and…
Read more ↗
AlloDx releases SuperNAT: a new generation of highly sensitive Nephrin antibody test
Recently, AlloDx launched a self-developed second-generation highly sensitive Nephrin antibody detection solution - Super Nephrin AntibodyTrap (SuperNAT for short), which can be used to detect…
Read more ↗
ddcfDNA quantitative technology upgrade!
ddcfDNA is a biomarker of non-invasive injury in kidney transplantation. Its detection accuracy is affected by specific pathological/physiological conditions, such as the patient's pregnancy, tumor…
Read more ↗
New: Comprehensive Genetic Testing for Alport Syndrome
Alport syndrome (AS), also known as hereditary progressive nephritis, is a primary glomerular basement membrane disease caused by mutations in the gene COL4An (n=3, 4, 5) encoding the α3-α5 chain of…
Read more ↗No matching content. Try another keyword or view all categories.